It is difficult to generalize how long a liver cancer patient can live after interventional therapy, and it depends on the patient’s condition and corresponding adjuvant treatment, as follows: 1. Condition: interventional therapy is usually seen in the case of middle and late stage liver cancer, which can be used without surgical resection, and is a non-curative treatment method. However, if the patient is in poor health and combined with underlying diseases, such as hypertension, coronary heart disease, diabetes or renal insufficiency, the survival time may be greatly affected, and some of them may not even reach one year; 2. adjuvant therapy: if active treatment, such as interventional embolization with targeted tumor therapy, the survival time may be longer, and 20%-40% of patients may live longer than three years. Three years, and a few patients with good results even exceed five years.